Philip Donenberg
Director/Board Member presso AVROBIO, INC.
Patrimonio netto: 330 059 $ in data 31/03/2024
Profilo
Philip B.
Donenberg is an Independent Director at Avrobio, Inc. since 2018 and at Taysha Gene Therapies, Inc. since 2020.
He previously worked as a Controller at Unimed Pharmaceuticals LLC from 1995 to 1998.
In 2018, he served as the Chief Financial Officer & Senior Vice President at Assertio Therapeutics, Inc. From 1998 to 2013, he held the position of Chief Financial Officer, Secretary & Senior VP at ANI Pharmaceuticals, Inc. He also worked as a Controller at Molecular Geriatrics Corp from 1993 to 1994.
Mr. Donenberg has an undergraduate degree from the University of Illinois At Urbana–Champaign.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 18/09/2023 | 114 111 ( 0.06% ) | 327 499 $ | 31/03/2024 | |
AVROBIO INC
0.00% | 06/06/2023 | 2 000 ( 0.00% ) | 2 560 $ | 31/03/2024 |
Posizioni attive di Philip Donenberg
| Società | Posizione | Inizio |
|---|---|---|
| AVROBIO, INC. | Director/Board Member | 20/06/2018 |
| TAYSHA GENE THERAPIES, INC. | Director/Board Member | 31/08/2020 |
Precedenti posizioni note di Philip Donenberg
| Società | Posizione | Fine |
|---|---|---|
Jaguar Gene Therapy LLC
 Jaguar Gene Therapy LLC Medical/Nursing ServicesHealth Services Jaguar Gene Therapy LLC is a company that aims to accelerate breakthroughs in gene therapy for patients suffering from severe genetic diseases. The company is based in Lake Forest, IL. The company's unrelenting commitment is to advocate boldly and care fiercely for patients and families. The company works together to confront the challenges of treating complex diseases and are advancing their initial pipeline that targets diseases with significant unmet need in sizeable patient populations. Joseph Nolan has been the CEO of the company since 2020. | Director of Finance/CFO | 01/03/2023 |
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Director of Finance/CFO | 30/11/2018 |
| AVEXIS INC | Director of Finance/CFO | 15/06/2018 |
| DIFFUSION PHARMA | Director of Finance/CFO | 01/09/2016 |
RestorGenex Corp.
 RestorGenex Corp. Pharmaceuticals: MajorHealth Technology RestorGenex Corp. operates as a specialty biopharmaceutical company, which focuses on developing products for dermatology, ophthalmology, and oncology. It products includes novel PI3K/Akt/mTOR pathway inhibitor which has completed two Phase I clinical trials for age-related macular degeneration and is in preclinical development in oncology, specifically glioblastoma multiforme. The company current pipeline also includes a soft anti-androgen compound for the treatment of acne vulgaris. RestorGenex was founded on March 14, 2008 and is headquartered in Buffalo Grove, IL. | Director of Finance/CFO | 08/01/2016 |
Formazione di Philip Donenberg
| University of Illinois At Urbana–Champaign | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| ANI PHARMACEUTICALS, INC. | Health Technology |
| AVROBIO, INC. | Health Technology |
| TAYSHA GENE THERAPIES, INC. | Health Technology |
| Aziende private | 11 |
|---|---|
Unimed Pharmaceuticals LLC
 Unimed Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Unimed Pharmaceuticals, Inc. manufactured pharmaceutical products. It provided multiple indications in the therapeutic areas of cardiology, men's health, HIV and other infectious diseases. The company was founded in 1999 and was headquartered in Marietta, GA. | Health Technology |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
Applied NeuroSolutions, Inc.
 Applied NeuroSolutions, Inc. BiotechnologyHealth Technology Applied NeuroSolutions, Inc. is a development stage biopharmaceutical company that engages in the research and development of a diagnostic tests to detect and novel therapeutics to treat Alzheimer's disease in humans. It researches and develops pharmaceuticals with an emphasis on products for infectious, inflammatory and other diseases. The company was founded on March 14, 1992 and is headquartered in Vernon Hills, IL. | Health Technology |
Molecular Geriatrics Corp
 Molecular Geriatrics Corp Miscellaneous Commercial ServicesCommercial Services Part of Applied NeuroSolutions, Inc., Molecular Geriatrics Corp is a private company that researches and develops pharmaceutical products for the treatment and detection of Alzheimer's and cancer. The company is based in Vernon Hills, IL. Molecular Geriatrics was acquired by Applied NeuroSolutions, Inc. on August 01, 2002. | Commercial Services |
| Xtramedics, Inc. | Consumer Non-Durables |
Gynex Pharmaceuticals, Inc.
 Gynex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Amgen, Inc., Gynex Pharmaceuticals, Inc. is a pharmaceutical concern. The private company is based in Vernon Hills, IL. Gynex Pharmaceuticals was acquired by Savient Pharmaceuticals, Inc. on August 09, 1993 for $47.87 million. | Health Technology |
7wire Ventures LLC
 7wire Ventures LLC Investment ManagersFinance 7wire Ventures LLC (7wire ventures) is a venture capital firm founded in 2011 by Matthew A. Tullman and Glen E. Tullman. The firm is headquartered in Chicago, Illinois. | Finance |
RestorGenex Corp.
RestorGenex Corp. Pharmaceuticals: MajorHealth Technology RestorGenex Corp. operates as a specialty biopharmaceutical company, which focuses on developing products for dermatology, ophthalmology, and oncology. It products includes novel PI3K/Akt/mTOR pathway inhibitor which has completed two Phase I clinical trials for age-related macular degeneration and is in preclinical development in oncology, specifically glioblastoma multiforme. The company current pipeline also includes a soft anti-androgen compound for the treatment of acne vulgaris. RestorGenex was founded on March 14, 2008 and is headquartered in Buffalo Grove, IL. | Health Technology |
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
Diffusion Pharmaceuticals, Inc.
 Diffusion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Diffusion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing novel therapies that enhance the body's ability to deliver oxygen. The firm's product candidate, Trans Sodium Crocetinate, is being developed to enhance the diffusion of oxygen to tissues with low oxygen levels, also known as hypoxia. The company was founded by David G. Kalergis and John L. Gainer in 2001 and is headquartered in Charlottesville, VA. | Health Technology |
Jaguar Gene Therapy LLC
Jaguar Gene Therapy LLC Medical/Nursing ServicesHealth Services Jaguar Gene Therapy LLC is a company that aims to accelerate breakthroughs in gene therapy for patients suffering from severe genetic diseases. The company is based in Lake Forest, IL. The company's unrelenting commitment is to advocate boldly and care fiercely for patients and families. The company works together to confront the challenges of treating complex diseases and are advancing their initial pipeline that targets diseases with significant unmet need in sizeable patient populations. Joseph Nolan has been the CEO of the company since 2020. | Health Services |
- Borsa valori
- Insiders
- Philip Donenberg
